Navigation Links
Derma Sciences Announces Numerous Clinical Presentations on MEDIHONEY(TM) Wound & Burn Dressings at Upcoming WUWHS Conference
Date:6/2/2008

Positive clinical outcomes showcased in poster presentations and satellite

symposium

PRINCETON, N.J., June 2 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (OTC Bulletin Board: DSCI), a provider of advanced wound care products, announced today that eleven clinical posters detailing the clinical usage of its newly released MEDIHONEY(TM) Wound & Burn Dressings with Active Leptospermum Honey will be presented at the upcoming 3rd World Union of Wound Healing Societies (WUWHS) conference. This conference, being held in Toronto on June 5-9, takes place every four years and brings together the global thought leaders on advancements in wound care. Additionally, the company has announced that a one-hour satellite symposium will discuss the benefits of Active Leptospermum Honey and its role in advanced wound care.

Chairman and CEO Ed Quilty said, "The clinical outcomes evidence generated thus far for MEDIHONEY since the product's launch late last year has been exceptional. It is now becoming clear that the dressings are beginning to serve an important role as clinicians' first choice for wounds that have not progressed with standard care, making up roughly 50% of all chronic wounds. The eleven posters being presented at the WUWHS showcase the variety of wound types being treated successfully with MEDIHONEY. This evidence, combined with the satellite symposium, should have great impact on the conference attendees, and will contribute to the ramp up of global sales of the product."

The abstracts include the following:

1. "Active Leptospermum Honey Impregnated Calcium Alginate Dressing

Treatment Options for Medically Compromised Patients", Elizabeth Bodie

Gross, RN, NP, WCC.

2. "Wound Healing Experiences using a Honey Based Product", Mary Brennan,

RN, MBA, CWON, Long Island Jewish Medical Center.

3. "Active Leptospermum Honey Impregnated Calcium Alginate Wound Dressing

Facilitates Healing in Elderly Patients with Painful Chronic Wounds

Unable to Tolerate Silver Containing Dressings", Loren Hayes, ARNP-BC,

MS(N), CS-BC, MS, CWCN, CWS, FACCWS, DAPWCA, Wound Technology Network.

4. "Utilizing Active Leptospermum Honey Alginate in the Treatment of

Recalcitrant Lower Extremity Ulcerations", Steven Kavros, DPM, Gonda

Vascular Wound Healing Center, Mayo Clinic.

5. "Favorable Treatment Outcomes of Chronic Leg Ulcers with the Use of a

New Active Leptospermum Honey Alginate Dressing", Dr. Paul A. Ligouri,

MD and Kim L. Peters, RN, CWS, Whittier Rehabilitation Hospital.

6. "A New Active Leptospermum Honey Impregnated Calcium Alginate Dressing

has a Positive Impact on a Wide Variety of Wound Types", Dr. Paul A.

Ligouri, MD and Kim L. Peters, RN, CWS, Whittier Rehabilitation

Hospital.

7. "Chronic Lower Extremity Ulceration - Use of an Active Leptospermum

Impregnated Alginate to Accelerate Wound Closure", Matt Regulski, DPM,

Toms River Foot and Ankle Surgical Associates.

8. "Use of new Active Leptospermum Honey Dressings in Non-healing

Wounds", Becky Strilko, RN, CWOCN, Silver Cross Hospital.

9. "The Challenges of Chronic Venous Leg Ulcers", Kathy Tavernelli,

RN-BC, BSN, CWOCN, Cleveland Clinic Home Care.

10. "The Voice of Experience: Wound Management using Active Leptospermum

Honey Impregnated Alginate Dressings", Dorothy Weir, RN, CWON, CWS,

Director of Wound Healing Center at Osceola Regional Medical Center.

11. "Use of Honey for Wound Healing", Karen Zulkowski, RN, CWOCN, DNsc,

Montana State University.

The Satellite Symposium, taking place on Saturday, June 7 at 12:45 pm, is titled "The Antimicrobial and Wound Healing Effectiveness of Active Leptospermum Honey: Mechanisms of Action and Review of Current Evidence." The symposium will feature a lecture by Dr. Rose Cooper, PhD, Professor in Microbiology, University of Wales Institute, Cardiff, UK, as well as a lecture by Dr. Georgina Gethin, PhD, RGN, DipHE Wound Care Lecturer at the Research Centre of Clinical Nursing and Midwifery, Royal College of Surgeons, Ireland. Dr. Cooper will present information on the mechanisms of action of Active Leptospermum Honey, as well as her findings on activity against biofilms and the inability of organisms to select for resistance. Dr. Gethin will present clinical evidence derived from her randomized controlled study comparing the antimicrobial activity and wound healing effectiveness of Active Leptospermum Honey against a standard advanced wound care dressing, as well as evidence from her study on Active Leptospermum Honey's effect on pH modulation on chronic wounds.

About Derma Sciences

Derma Sciences is a global manufacturer and marketer of advanced wound-care products. Its key product, MEDIHONEY, is sold throughout the world by Derma Sciences and Comvita New Zealand -- the licensor of the patented honey-based technology -- and is the leading brand of honey-based dressings for the management of wounds and burns. The product has been shown to be effective in a variety of wounds and burns, and was recently the focus of a large-scale randomized controlled trial on leg ulcers. Derma has two products in development: the NIMBUS technology based line of barrier gauze dressings, and DSC127, the company's novel angiotensin analog for accelerated wound healing and scar reduction. The barrier technology was licensed from Quick-Med in Q1 of 2007 and is pending its initial FDA marketing clearance. DSC127 was licensed from The University of Southern California in Q4 of 2007 and is entering into a Phase II study, with anticipated initial patient enrollment to begin in Q3 of 2008. For more information about Derma Sciences, Inc., visit its home page on the Internet at http://www.dermasciences.com.

About the WUWHS

The World Union of Wound Healing Societies is a consortium of associations with a single mission: to enhance the lives of persons with wounds worldwide. The WUWHS executives includes opinion leaders in wound care from Australia, Belgium, Canada, France, Denmark, the United Kingdom and the United States. Wound care professionals from around the world will attend this congress to appraise information on the latest developments in wound care, network with and meet colleagues, and share their experiences. This congress is the most important wound-care meeting in 2008 and will be attended by health care professionals from all disciplines who have an interest in wound care. Hosting Societies include The Canadian Association of Wound Care (CAWC), The Canadian Association of Enterostomal Therapy (CAET), The Registered Nurses' Association of Ontario (RNAO), The American Professional Wound Care Association (APWCA), The National Pressure Ulcer Advisory Panel (NPUAP) and The European Tissue Repair Society (ETRS). The conference is held every four years. Prior locations have been Australia and Paris.

Contact: Derma Sciences, Inc. Allen & Caron Inc

Edward J. Quilty Rudy Barrio (US Investors)

Chairman and CEO r.barrio@allencaron.com

equilty@dermasciences.com

(609) 514-4744 Brian Kennedy (media)

brian@allencaron.com

(212) 691-8087


'/>"/>
SOURCE Derma Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Dermatologists Release Psoriasis Care Guidelines
2. Soon to Be Released: Lutronic Announces the MOSAIC eCO2, the Worlds First Smart Fractional CO2 Laser System for Treating Aesthetic and Dermatological Conditions, Will Soon Be Coming to the U.S. Market for Commercial Use
3. New Jersey Dermatologist Volunteers Show Golf Enthusiasts How to Play Safe in the Sun
4. Animal Dermatology Clinic Tustin Announces Dr. Russell Muses Appointment as the Member-At-Large for the Executive Board of the American College of Veterinary Dermatology
5. American Academy of Dermatology Issues New Guidelines for the Management of Psoriasis and Psoriatic Arthritis
6. Womens Dermatologic Society Announces Collaboration on Americas Ethnic Skin: An Al Roker Health Special
7. Lutronic Inc. Announces FDA Clearance of Its Spectra VRM III Q-Switched Nd: Yag Laser System for Treating a Broad Spectrum of Dermatological and Aesthetic Conditions
8. Derma Sciences MEDIHONEY(TM) Profiled By ABC News Philadelphia Affiliate
9. Mergent, Inc. Announces Changes to the HealthShares(TM) Composite Index, Dermatology and Wound Care Index and Orthopedic Repair Index - Correction
10. Mergent, Inc. Announces Changes to the HealthShares(TM) Composite Index, HealthShares(TM) Dermatology and Wound Care Index and HealthShares(TM) Orthopedic Repair Index
11. Dr. Lance H. Brown President-Elect of Dermatologic Society of Greater New York Fights Misconceptions About Sun Protection and Skin Care in Support of Skin Cancer Awareness Month - May
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , ... June 24, 2016 , ... June 19, 2016 ... dangers associated with chronic pain and the benefits of holistic treatments, Serenity Recovery ... are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Global law firm ... 2016 Legal Elite. The attorneys chosen by their peers for this recognition are considered ... Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite ...
(Date:6/24/2016)... ... ... BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a ... an hour by 2020 and then adjusting it yearly to increase at the same rate ... assure the wage floor does not erode again, and make future increases more predictable. , ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... is proud to recognize Dr. Barry M. Weintraub as a prominent plastic surgeon ... beautiful women in the world, and the most handsome men, look naturally attractive. ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm Slone Partners ... extensive sequencing and genomics experience, as Vice President of North American Capital Sales at ... responsible for leading the sales team in the commercialization of the HTG EdgeSeq system ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology: